SE9000658D0 - Mittel zur behandlung der schlaf-apnoe - Google Patents

Mittel zur behandlung der schlaf-apnoe

Info

Publication number
SE9000658D0
SE9000658D0 SE9000658A SE9000658A SE9000658D0 SE 9000658 D0 SE9000658 D0 SE 9000658D0 SE 9000658 A SE9000658 A SE 9000658A SE 9000658 A SE9000658 A SE 9000658A SE 9000658 D0 SE9000658 D0 SE 9000658D0
Authority
SE
Sweden
Prior art keywords
treatment
sleep apnoe
sleep
apnoe
azaoctane
Prior art date
Application number
SE9000658A
Other languages
English (en)
Other versions
SE9000658L (sv
SE510167C2 (sv
Inventor
K-D Voelger
Original Assignee
Roehm Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma Gmbh filed Critical Roehm Pharma Gmbh
Publication of SE9000658D0 publication Critical patent/SE9000658D0/sv
Publication of SE9000658L publication Critical patent/SE9000658L/sv
Publication of SE510167C2 publication Critical patent/SE510167C2/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Electrotherapy Devices (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
SE9000658A 1989-03-14 1990-02-23 Användning av 2 - isopropyl-2,8-bis-(3,4-dimetoxifenyl)-6- metyl-6-azaoktannitril (Verapamil) för framställning av terapeutiska beredningar för behandling av sömnapné SE510167C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3908232A DE3908232C2 (de) 1989-03-14 1989-03-14 Verwendung von Verapamil zur Behandlung der Schlaf-Apnoe

Publications (3)

Publication Number Publication Date
SE9000658D0 true SE9000658D0 (sv) 1990-02-23
SE9000658L SE9000658L (sv) 1990-09-15
SE510167C2 SE510167C2 (sv) 1999-04-26

Family

ID=6376287

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9000658A SE510167C2 (sv) 1989-03-14 1990-02-23 Användning av 2 - isopropyl-2,8-bis-(3,4-dimetoxifenyl)-6- metyl-6-azaoktannitril (Verapamil) för framställning av terapeutiska beredningar för behandling av sömnapné

Country Status (7)

Country Link
US (1) US5093131A (sv)
CH (1) CH679275A5 (sv)
DE (1) DE3908232C2 (sv)
FR (1) FR2644344B1 (sv)
GB (1) GB2230443B (sv)
IT (1) IT1241589B (sv)
SE (1) SE510167C2 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009127210A1 (en) * 2008-04-14 2009-10-22 Soerensen Kurt Virring Vasodilating agents for the treatment of sleep attacks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658500C2 (de) * 1976-12-23 1986-10-09 Knoll Ag, 6700 Ludwigshafen Pharmazeutische Präparate mit kardioprotektiver Wirkung
DE3517820A1 (de) * 1985-05-17 1986-11-20 Röhm Pharma GmbH, 6108 Weiterstadt Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung

Also Published As

Publication number Publication date
DE3908232A1 (de) 1990-09-20
CH679275A5 (sv) 1992-01-31
DE3908232C2 (de) 1998-02-26
FR2644344A1 (fr) 1990-09-21
GB2230443B (en) 1992-12-16
SE9000658L (sv) 1990-09-15
US5093131A (en) 1992-03-03
SE510167C2 (sv) 1999-04-26
IT1241589B (it) 1994-01-19
IT9067177A1 (it) 1991-09-13
GB2230443A (en) 1990-10-24
GB9005605D0 (en) 1990-05-09
FR2644344B1 (fr) 1995-03-31
IT9067177A0 (it) 1990-03-13

Similar Documents

Publication Publication Date Title
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE124260T1 (de) Verwendung von melatonin zur behandlung des prämenstruellen syndroms.
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE69634900D1 (de) Proteintyrosine-kinaseinhibitoren zur behandlung der osteoarthritis
DE69201128D1 (de) Behandlung von neoplastischen krankenheiten mit interleukin-10.
DE69418601D1 (de) Guanidinderivate mit therapeutischer wirkung
ATE416164T1 (de) Pharmazeutische zusammenstellungen zur prävention und behandlung von zns-erkrankungen
ATE257378T1 (de) Phenylacetylglutamin, phenylacetylisoglutamin, und/oder phenylacetat zur behandlung von neoplastischen erkrankungen
DK586387D0 (da) Piperidinderivater til behandling af smertetilstande
DE3884895D1 (de) Verwendung von Bezafibrat zur Behandlung von Diabetes.
ATE191342T1 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
SE9000658D0 (sv) Mittel zur behandlung der schlaf-apnoe
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE81006T1 (de) Verfahren zur anwendung von diltiazem, verapamil oder nifedipin mit aktivitaet zur behandlung von schlaganfaellen.
DE3873188D1 (de) Verwendung von nigerizin zur herstellung eines mittels zur behandlung von virus-erkrankungen.
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
RU95120819A (ru) Наружное средство и способ лечения неврологических заболеваний и заболеваний опорно-двигательного аппарата с болевым синдромом и отечностью
RU94002713A (ru) Способ лечения детей с синдромом удлиненного интервала qт (романо-уорда)
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
RU97117562A (ru) Способ лечения болезней пародонта
SE8601421L (sv) Harbehandlingsmedel och forfarande for kosmetisk behandling av har och harbottnar